Search | IOVS | ARVO Journals

Showing 1 – 20 of 29

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Hypoxic Ischemic Encephalopathy and Visual outcomes: A Single Center Retrospective Study

Sana A alhajri; De-Ann M Pillers; Alan Schwartz; Burce Mocan; Zaynab Kadhe; Cem Mocan

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3503.

ARVO Annual Meeting Abstract June 2021

Intrauterine Growth Restriction (IUGR) as a Risk Factor for Retinopathy of Prematurity (ROP) Severity in a Population of Black Infants

Meaghan McGowan; Hernan Sierra-Fernandez; Zaynab Kadhem; Alan Schwartz; Felix Chau; R.V. Paul Chan; De-Ann M Pillers

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3263.

ARVO Annual Meeting Abstract July 2019

KCNJ13 nonsense mutation causes Leber Congenital Amaurosis (LCA16) in man but is lethal in mouse model

De-Ann M Pillers; Pawan K Shahi; Bikash Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4939.

ARVO Annual Meeting Abstract July 2018

Effectiveness of near-cognate amino acid insertion for KCNJ13 nonsense suppression

Bikash R Pattnaik; Raghu Ramesh; Pawan K Shahi; Sara Counter; Sabrina Stulo; De-Ann M Pillers

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5384.

ARVO Annual Meeting Abstract July 2018

Rescue of Kir7.1 function by gene augmentation in LCA16 patient derived iPSC-RPE cells

Pawan K Shahi; Divya Sinha; Sabrina Stulo; De-Ann M Pillers; David M Gamm; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1196.

ARVO Annual Meeting Abstract July 2018

Oxytocin Receptor Expression in the Retinal Pigment Epithelium Increases with Retinal Maturation

Nathaniel Walter York; Hannah Labarge; Allison Lutz; De-Ann M Pillers; Nader Sheibani; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3117.

ARVO Annual Meeting Abstract June 2017

KCNJ13 Gene Augmentation Therapy to Treat Blindness due to Kir7.1 Defects

Pawan K Shahi; Sabrina Stulo; Dalton James Hermans; De-Ann M Pillers; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4091.

ARVO Annual Meeting Abstract June 2017

Mouse Retina after Kcnj13 Inhibition by RNAi is a Model for LCA and SVD

Bikash R Pattnaik; Pawan K Shahi; Bryce Aul; Akshita Pattnaik; Yu Chang; De-Ann M Pillers

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5880.

ARVO Annual Meeting Abstract June 2017

Oxytocin Receptor Ontogeny in the Mouse RPE

Nathaniel York; Allison Lutz; De-Ann M Pillers; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):103.

ARVO Annual Meeting Abstract September 2016

Molecular Mechanisms of Oxytocinergic Signaling and its Inhibition of Kir7.1 in the RPE

Nathaniel York; Patrick Halbach; Michelle Chiu; Ian Bird; De-Ann M Pillers; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):240.

ARVO Annual Meeting Abstract September 2016

TRKB Receptor Agonist 7,8-DHF Alters Effect of Hypoxic-Ischemic Encephalopathy (HIE) on Mouse ERG

De-Ann M Pillers; Xingyu Liu; Eshwar Udo; Ulas Cikla; Peter Ferrazzano; Pelin Cengiz; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):609.

ARVO Annual Meeting Abstract September 2016

Read-through of LCA16 nonsense mutation therapy using iPS-RPE cells

Pawan K Shahi; Dalton Hermans; Nathaniel York; Simran Brar; Katarzyna Borys; Elizabeth E Capowski; Ellen Welch; De-Ann M Pillers; David M Gamm; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1103.

ARVO Annual Meeting Abstract June 2015

Human LCA16 iPSC-RPE recapitulates the phenotype associated with the nonsense mutation c.158 G>A (p.W53X)

Bikash R Pattnaik; Pawan Shahi; Katarzyna Borys; Dalton Hermans; Nathaniel York; Elizabeth E Capowski; Simran Brar; De-Ann M Pillers; David M Gamm

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3175.

ARVO Annual Meeting Abstract June 2015

Effect of Hypoxic-Ischemic Encephalopathy (HIE) on the Mouse ERG

De-Ann M Pillers; Pelin Cengiz; Xingying Liu; Ulas Cikla; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):476.

ARVO Annual Meeting Abstract June 2015

Read-through of LCA16 ( KCNJ13 ) nonsense mutations W53X and R166X by RTC-14

Pawan K Shahi; Vladimer Bakhutashvili; Simran Brar; Katherine Umhoefer; Richard Gatti; De-Ann M Pillers; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2463.

ARVO Annual Meeting Abstract June 2015

RPE Kir7.1 inhibition or knocked-down results in reduced amplitude mouse ERG that emulates findings in SVD and LCA16

xinying liu; Pawan K Shahi; Bikash R Pattnaik; De-Ann M Pillers; Jerod S Denton

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2474.

Retinal Cell Biology February 2015

Oxytocin Expression and Function in the Posterior Retina: A Novel Signaling Pathway

PDF

Patrick Halbach; De-Ann M. Pillers; Nathaniel York; Matti P. Asuma; Michelle A. Chiu; Wenxiang Luo; Sara Tokarz; Ian M. Bird; Bikash R. Pattnaik
TAGS: macaca mulatta, oxytocin, oxytocin receptor, retina, signal pathway, signal transduction, signal transduction pathways, rna, messenger, retinal pigment cell, retinal cone
Invest. Ophthalmol. Vis. Sci.. 2015; 56(2):751-760. https://doi.org/10.1167/iovs.14-15646

ARVO Annual Meeting Abstract April 2014

Oxytocinergic Signaling via GPCR in a Single HEK293 Cell with Stable Expression of the Oxytocin Receptor

De-Ann M Pillers; Michelle Chiu; Patrick Halbach; Nathan York; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2951.

ARVO Annual Meeting Abstract April 2014

A Novel Nonsense Mutation in KCNJ13 Causes Leber Congenital Amaurosis

Bikash R Pattnaik; Meghan J Marino; John Chiang; De-Ann M Pillers; Elias I Traboulsi

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3283.

ARVO Annual Meeting Abstract March 2012

Expression of Oxytocin Receptor Transcripts in the Retina

De-Ann M. Pillers; Wenxiang Luo; Patrick Halbach; Bikash Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1600.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Hypoxic Ischemic Encephalopathy and Visual outcomes: A Single Center Retrospective Study

Intrauterine Growth Restriction (IUGR) as a Risk Factor for Retinopathy of Prematurity (ROP) Severity in a Population of Black Infants

KCNJ13 nonsense mutation causes Leber Congenital Amaurosis (LCA16) in man but is lethal in mouse model

Effectiveness of near-cognate amino acid insertion for KCNJ13 nonsense suppression

Rescue of Kir7.1 function by gene augmentation in LCA16 patient derived iPSC-RPE cells

Oxytocin Receptor Expression in the Retinal Pigment Epithelium Increases with Retinal Maturation

KCNJ13 Gene Augmentation Therapy to Treat Blindness due to Kir7.1 Defects

Mouse Retina after Kcnj13 Inhibition by RNAi is a Model for LCA and SVD

Oxytocin Receptor Ontogeny in the Mouse RPE

Molecular Mechanisms of Oxytocinergic Signaling and its Inhibition of Kir7.1 in the RPE

TRKB Receptor Agonist 7,8-DHF Alters Effect of Hypoxic-Ischemic Encephalopathy (HIE) on Mouse ERG

Read-through of LCA16 nonsense mutation therapy using iPS-RPE cells

Human LCA16 iPSC-RPE recapitulates the phenotype associated with the nonsense mutation c.158 G>A (p.W53X)

Effect of Hypoxic-Ischemic Encephalopathy (HIE) on the Mouse ERG

Read-through of LCA16 ( KCNJ13 ) nonsense mutations W53X and R166X by RTC-14

RPE Kir7.1 inhibition or knocked-down results in reduced amplitude mouse ERG that emulates findings in SVD and LCA16

Oxytocin Expression and Function in the Posterior Retina: A Novel Signaling Pathway

Oxytocinergic Signaling via GPCR in a Single HEK293 Cell with Stable Expression of the Oxytocin Receptor

A Novel Nonsense Mutation in KCNJ13 Causes Leber Congenital Amaurosis

Expression of Oxytocin Receptor Transcripts in the Retina

To View More...

You must be signed into an individual account to use this feature.